TRACT is an international, inter-sectoral, multi-disciplinary project providing Marie Skłodowska-Curie PhD Fellowships to early stage researchers (ESRs) with the potential to become the leaders of tomorrow in cancer research. This project has received funding from the European Union’s Horizon 2020 research & innovation programme under the Marie Skłodowska-Curie grant agreement No. 721906. PhD Fellows will complete three year research projects in three critical thematic areas; biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. TRACT will enable Fellows to discover novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. Through our SME/industrial partners, PhD Fellows will be exposed to next-generation technologies in cancer diagnosis, metabolism, genome scale CRISPR knockout and next generation sequencing, imaging, biomarker identification, exosome isolation/analysis, medicinal chemistry, target identification/validation, bioinformatics and drug development. Fellows trained through the TRACT network will be uniquely positioned for careers in academia, industry or as entrepreneurs. A living allowance of up to €3110 per month subject to local taxes (depending on the country of the host institution) is available for recruited researchers along with a mobility allowance and family allowance. In total, eleven PhD positions are available within a number of Institutions listed below with a start date of 1st March 2017.